Revolka signed master service agreement with daiichi sankyo

Tokyo--(business wire)--revolka ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform (norio hamamatsu, president and ceo) signed a master service agreement with daiichi sankyo co., ltd. (hiroyuki okuzawa, president and coo). revolka will create and deliver highly functional proteins, in collaboration with daiichi sankyo co., ltd. by using its proprietary protein engineering platform technology, called aiprotein®: a robust directed protein evol.
ATRO Ratings Summary
ATRO Quant Ranking